Management of IBD during the COVID-19 outbreak: resetting clinical priorities

The coronavirus disease (COVID-19) worldwide outbreak has led to a dramatic challenge for all healthcare systems, including inflammatory bowel disease (IBD) centres. Here, we describe the fast changes and clinical issues that IBD specialists could face during this SARS-CoV-2 infection pandemic, high...

Descripción completa

Detalles Bibliográficos
Autores principales: Danese, Silvio, Cecconi, Maurizio, Spinelli, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095422/
https://www.ncbi.nlm.nih.gov/pubmed/32214232
http://dx.doi.org/10.1038/s41575-020-0294-8
_version_ 1783510667132665856
author Danese, Silvio
Cecconi, Maurizio
Spinelli, Antonino
author_facet Danese, Silvio
Cecconi, Maurizio
Spinelli, Antonino
author_sort Danese, Silvio
collection PubMed
description The coronavirus disease (COVID-19) worldwide outbreak has led to a dramatic challenge for all healthcare systems, including inflammatory bowel disease (IBD) centres. Here, we describe the fast changes and clinical issues that IBD specialists could face during this SARS-CoV-2 infection pandemic, highlighting the potential rearrangements of care and resetting of clinical priorities.
format Online
Article
Text
id pubmed-7095422
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70954222020-03-26 Management of IBD during the COVID-19 outbreak: resetting clinical priorities Danese, Silvio Cecconi, Maurizio Spinelli, Antonino Nat Rev Gastroenterol Hepatol Comment The coronavirus disease (COVID-19) worldwide outbreak has led to a dramatic challenge for all healthcare systems, including inflammatory bowel disease (IBD) centres. Here, we describe the fast changes and clinical issues that IBD specialists could face during this SARS-CoV-2 infection pandemic, highlighting the potential rearrangements of care and resetting of clinical priorities. Nature Publishing Group UK 2020-03-25 2020 /pmc/articles/PMC7095422/ /pubmed/32214232 http://dx.doi.org/10.1038/s41575-020-0294-8 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Danese, Silvio
Cecconi, Maurizio
Spinelli, Antonino
Management of IBD during the COVID-19 outbreak: resetting clinical priorities
title Management of IBD during the COVID-19 outbreak: resetting clinical priorities
title_full Management of IBD during the COVID-19 outbreak: resetting clinical priorities
title_fullStr Management of IBD during the COVID-19 outbreak: resetting clinical priorities
title_full_unstemmed Management of IBD during the COVID-19 outbreak: resetting clinical priorities
title_short Management of IBD during the COVID-19 outbreak: resetting clinical priorities
title_sort management of ibd during the covid-19 outbreak: resetting clinical priorities
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095422/
https://www.ncbi.nlm.nih.gov/pubmed/32214232
http://dx.doi.org/10.1038/s41575-020-0294-8
work_keys_str_mv AT danesesilvio managementofibdduringthecovid19outbreakresettingclinicalpriorities
AT cecconimaurizio managementofibdduringthecovid19outbreakresettingclinicalpriorities
AT spinelliantonino managementofibdduringthecovid19outbreakresettingclinicalpriorities

Ejemplares similares